Comment
doi: 10.7326/M16-1784.
Epub 2016 Aug 23.
Are Microbial Politics Local?
Affiliations
- PMID: 27548329
- DOI: 10.7326/M16-1784
Item in Clipboard
Comment
Are Microbial Politics Local?
Ann Intern Med.
.
Erratum in
-
Correction: Are Microbial Politics Local?Ann Intern Med. 2016 Nov 1;165(9):679. doi: 10.7326/L16-0532. Ann Intern Med. 2016. PMID: 27802471 No abstract available.
No abstract available
Comment on
-
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.Ann Intern Med. 2016 Nov 1;165(9):609-616. doi: 10.7326/M16-0271. Epub 2016 Aug 23. Ann Intern Med. 2016. PMID: 27547925 Free PMC article. Clinical Trial.
Similar articles
-
Fecal microbial transplantation in a pediatric case of recurrent Clostridium difficile infection and specific antibody deficiency.Pediatr Allergy Immunol. 2016 Dec;27(8):872-874. doi: 10.1111/pai.12619. Epub 2016 Sep 16. Pediatr Allergy Immunol. 2016. PMID: 27496525 No abstract available.
-
Clarifying the management of Clostridium difficile infection.BMJ. 2015 Nov 19;351:h6130. doi: 10.1136/bmj.h6130. BMJ. 2015. PMID: 26584845 No abstract available.
-
Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?Expert Rev Gastroenterol Hepatol. 2018 May;12(5):435-438. doi: 10.1080/17474124.2018.1465818. Epub 2018 Apr 20. Expert Rev Gastroenterol Hepatol. 2018. PMID: 29667436 No abstract available.
-
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.J Clin Microbiol. 2017 Apr;55(4):1002-1010. doi: 10.1128/JCM.02327-16. Epub 2017 Jan 11. J Clin Microbiol. 2017. PMID: 28077694 Free PMC article. Review.
-
Clostridium difficile Infection and Fecal Microbiota Transplant.AACN Adv Crit Care. 2016 Jul;27(3):324-337. doi: 10.4037/aacnacc2016703. AACN Adv Crit Care. 2016. PMID: 27959316 Free PMC article. Review.
Cited by
-
Prevalence of Comorbid Factors in Patients With Recurrent Clostridioides difficile Infection in ECOSPOR III, a Randomized Trial of an Oral Microbiota-Based Therapeutic.Clin Infect Dis. 2023 Nov 30;77(11):1504-1510. doi: 10.1093/cid/ciad448. Clin Infect Dis. 2023. PMID: 37539715 Free PMC article. Clinical Trial.
-
Assessment of Quality of Life Among Patients With Recurrent Clostridioides difficile Infection Treated with Investigational Oral Microbiome Therapeutic SER-109: Secondary Analysis of a Randomized Clinical Trial.JAMA Netw Open. 2023 Jan 3;6(1):e2253570. doi: 10.1001/jamanetworkopen.2022.53570. JAMA Netw Open. 2023. PMID: 36716031 Free PMC article. Clinical Trial.
-
SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.Clin Infect Dis. 2021 Jun 15;72(12):2132-2140. doi: 10.1093/cid/ciaa387. Clin Infect Dis. 2021. PMID: 32255488 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
